Skip to content

Clinical trials

Recruiting Obesity trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Status: Recruiting Country / region: China Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20111
20172
20182
20192
20202
20211
20224
20234
202415
202539
202650

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting124

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China-Japan Friendship Hospital6
Eli Lilly and Company6
Gan & Lee Pharmaceuticals.6
AstraZeneca4
Fujian Shengdi Pharmaceutical Co., Ltd.4
Hangzhou Sciwind Biosciences Co., Ltd.4
Innovent Biologics (Suzhou) Co. Ltd.4
Novo Nordisk A/S4
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School4
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity124
Overweight71
Diabetes Mellitus, Type 212
Weight Loss11
Metabolic Syndrome8
Hypertension6
Sleep Apnea, Obstructive6
Renal Insufficiency, Chronic5
Diabetes Mellitus4
Heart Failure4

Trials

Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.